Everest Re Group, Ltd. (RE)
(Delayed Data from NYSE)
$238.66 USD
+1.87 (0.79%)
Updated May 3, 2019 04:02 PM ET
After-Market: $238.74 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$238.66 USD
+1.87 (0.79%)
Updated May 3, 2019 04:02 PM ET
After-Market: $238.74 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Best Growth Stocks to Buy for February 15th
by Zacks Equity Research
RE, GPK and ELF made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 15, 2023.
Should Value Investors Buy Argo Group (ARGO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New Strong Buy Stocks for February 13th
by Zacks Equity Research
GWRS, WFRD, HUYA, DBD and RE have been added to the Zacks Rank #1 (Strong Buy) List on February 13, 2023.
Best Growth Stocks to Buy for February 13th
by Zacks Equity Research
RE, LW and ELF made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 13, 2023.
Best Value Stocks to Buy for February 13th
by Zacks Equity Research
DBD, RE and BDC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 13, 2023.
Best Income Stocks to Buy for February 13th
by Zacks Equity Research
RE, GWRS and ATHM made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 13, 2023.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Everest Re (RE) Q4 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Everest Re's (RE) Q4 results reflect higher premiums across its Reinsurance and Insurance businesses and better pricing as well as terms and conditions and deepening relationships with new and existing core clients.
Everest Re (RE) Beats Q4 Earnings Estimates
by Zacks Equity Research
Everest Re (RE) delivered earnings and revenue surprises of 31.43% and 2.89%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q4 Earnings on Feb 8: RE, LNC & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to aid fourth-quarter results of insurers like RE, LNC, SLF and RDN.
Is a Surprise Coming for Everest Re (RE) This Earnings Season?
by Zacks Equity Research
Everest Re (RE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Arch Capital Group (ACGL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Arch Capital (ACGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Everest Re (RE) Pull Off a Surprise in Q4 Earnings?
by Zacks Equity Research
Everest Re's (RE) Q4 results are likely to benefit from growth across most lines of business driven by positive rate and exposure increases, new business and strong renewal retention, offset by higher cat loss.
Everest Re (RE) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Everest Re (RE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Lower Premiums Dampen MetLife's (MET) Q4 Earnings?
by Zacks Equity Research
MetLife's (MET) fourth-quarter results are likely to be hurt by a fall in premiums and net investment income, partly offset by reduced COVID life insurance claims in U.S. business.
Unum Group (UNM) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Unum Group (UNM) Q4 results are likely to reflect favorable benefits experience, higher sales and higher persistency.
Will Chubb (CB) Pull Off a Surprise This Earnings Season?
by Zacks Equity Research
Chubb's (CB) Q4 earnings are likely to reflect strong premium retention and higher reinvestment rates on fixed maturities, offset by higher expenses.
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Zacks Industry Outlook Highlights Berkshire Hathaway, Chubb, The Progressive, The Travelers Companies and Everest Re Group
by Santanu Roy
Berkshire Hathaway, Chubb, The Progressive, The Travelers Companies and Everest Re Group are part of the Zacks Industry Outlook article.
5 Property & Casualty Insurers to Gain Despite Catastrophe Loss
by Tanuka De
Frequent catastrophes accelerating policy renewal rate and the resultant upward pricing pressure are likely to boost the performance of Zacks Property and Casualty Insurance industry players like BRK.B, CB, PGR, TRV and RE.
5 Insurance Stocks Likely to Zoom Past Q4 Earnings Estimates
by Kaibalya Pravo Dey
Increasing interest rates, growing awareness, the scaling of businesses and other factors are likely to have supported the fourth-quarter performances of insurers like Marsh & McLennan, American International, Aflac, Everest Re and Voya Financial.
Allstate (ALL) Unveils Preliminary Fourth-Quarter Estimates
by Zacks Equity Research
Allstate (ALL) expects its premiums to register year-over-year increase in the fourth quarter of 2022 resulting from continued rate increases. However, catastrophe losses might dampen its underwriting results.
RE vs. TKOMY: Which Stock Is the Better Value Option?
by Zacks Equity Research
RE vs. TKOMY: Which Stock Is the Better Value Option?
Is it Time to Add Everest Re (RE) Stock to Your Portfolio?
by Zacks Equity Research
Segmental strength, a solid capital position and favorable growth estimates poise Everest Re (RE) well for growth.
Everest Re (RE) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Everest Re (RE) have what it takes to be a top stock pick for momentum investors? Let's find out.